MAP PHARMACEUTICALS, INC. (MAPP) President and CEO Timothy S Nelson sells 30,000 Shares

President and CEO of MAP PHARMACEUTICALS, INC. (MAPP, Financial) Timothy S Nelson sells 30,000 shares of MAPP on 05/13/2010 at an average price of $17.09 a share.

Map Pharmaceuticals, Inc. has a market cap of $447.9 million; its shares were traded at around $17.03 with and P/S ratio of 8.3.

MAPP is in the portfolios of George Soros of Soros Fund Management LLC.

CEO Recent Trades:

  • Sell:: President and CEO Timothy S Nelson sold 30,000 shares of MAPP stock on 03/01/2010 at the average price of 14.47, the price of the stock has increased by 17.69% since.

  • Sell:: President and CEO Timothy S Nelson sold 20,000 shares of MAPP stock on 01/11/2010 at the average price of 12.17, the price of the stock has increased by 39.93% since.



CFO Recent Trades:

  • Sell:: CFO Christopher Y Chai sold 16,000 shares of MAPP stock on 03/24/2010 at the average price of 16.6, the price of the stock has increased by 2.59% since.



Directors and Officers Recent Trades:

  • Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 3,250 shares of MAPP stock on 05/03/2010 at the average price of 18.3, the price of the stock has decreased by 6.94% since.

  • Sell:: VP President, Gen Counsel &Sec Charlene A Friedman sold 10,155 shares of MAPP stock on 04/26/2010 at the average price of 18.03, the price of the stock has decreased by 5.55% since.

  • Sell:: VP President, Gen Counsel &Sec Charlene A Friedman sold 1,560 shares of MAPP stock on 04/14/2010 at the average price of 16.05, the price of the stock has increased by 6.11% since.

  • Sell:: SVP, Cor & Business Dev Anastasios Gianakakos sold 3,250 shares of MAPP stock on 04/01/2010 at the average price of 15.92, the price of the stock has increased by 6.97% since.

  • Sell:: Director Carl Goldfischer sold 262,786 shares of MAPP stock on 03/16/2010 at the average price of 16.21, the price of the stock has increased by 5.06% since.